Testimonials:

In Singh lab, we have established a translational pipeline for target discovery and development of new immunotherapies for treatment-refractory Glioblastoma, and every campaign we launch around a new target requires significant resources to deeply validate and optimize new therapeutics. "With their bold vision, Brain Cancer Canada has seen the promise in our research approach, and their funding provides support for bright young trainees to undertake the exploratory research required to venture into the unknown. Thank you, BCC, for funding the next generation of brain cancer researchers, as they will be the ones who will discover badly needed new treatment options for patients with treatment-resistant brain cancer." -Dr. Sheila Singh McMaster Children’s Hospital, Pediatric Neurosurgeon & Scientist